Displaying 1 - 10 of 10

Display:

12 24 48

Cirrhosis & Complications

5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View

Cirrhosis & Complications

5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View

Cirrhosis & Complications

5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View

Cirrhosis & Complications

5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View

Cirrhosis & Complications

5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk: Unmasking NASH: the hepatic face of metabolic dysregulation - ILC 2021

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk: Unmasking NASH: the hepatic face of metabolic dysregulation - ILC 2021

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk: Unmasking NASH: the hepatic face of metabolic dysregulation - ILC 2021

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk: Unmasking NASH: the hepatic face of metabolic dysregulation - ILC 2021

View

Metabolism, Alcohol & Toxicity

5

Novo Nordisk: Unmasking NASH: the hepatic face of metabolic dysregulation - ILC 2021

View

Displaying 1 - 10 of 10

Display:

12 24 48